Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, Others); Route of Administration (Oral, P

Gastrointestinal Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Acid Neutralizers, Antidiarrheal and Laxatives, Anti-Inflammatory Drugs, Antiemetic and Antinauseants, Biologics, Others); Route of Administration (Oral, Parenteral); Application (Inflammatory Ulcerative Colitis, Crohn's Disease, Irritable Bowel Syndrome, Gastroenteritis, Celiac Disease, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography

The gastrointestinal drugs market was valued at US$ 49,043.38 million in 2019 and is projected to reach US$ 71,300.28 million by 2027; it is expected to grow at a CAGR of 4.9% from 2020 to 2027.

The growth of the gastrointestinal drugs market is mainly attributed to factors such as rise in prevalence of gastrointestinal (GI) diseasesand increase in development of biologics. However, the market is likely to get impacted by the low awareness associated with gastrointestinal disorders in low-income economiesduring the forecast period.



Increasing development of biologics for the treatment of GI diseases is driving the growth of the market . In the last few years, new treatments called biologics are being used for the treatment of inflammatory diseases. Currently, the FDA has approved Humira, Cimzia, Remicade, Simponi, Tysabri, and Entyvio biologics for the treatment of Crohn’s disease and ulcerative colitis (UC). Biologics have revolutionized the IBD treatment, and their success in the treatment of these indications is driving the use of biologics in other GI conditions, such as celiac disease, eosinophilic esophagitis, and autoimmune hepatitis. The development of new medication is driving the growth of the market . For instance, in September 2019, Janssen Pharmaceutical received the European Commission approval for STELARA. It would be used in the treatment of moderately to severely active ulcerative colitis in adults. It is the first biologic treatment that would target the IL-12/IL-23 pathway, an important therapeutic target in UC. Apart from this, strategic initiatives by market players, such as product launch in untapped market s, are further driving the growth of the market . For instance, in July 2020, Takeda Pharmaceutical Company launched its blockbuster biologic drug Vedolizumab in India as part of its GI portfolio. Vedolizumab would be sold in India under the brand name Kynteles. It would be used for the treatment of chronic inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. The cases of GI disorders are on the rise in developing countries. For instance, there are currently around 1.5 million IBD patients in India. The introduction of new biologics in these market s is expected to drive the market growth during the forecast period.

Moreover, along with product launches, the market players are carrying out different strategies to add innovative therapies in their product portfolio. This is further driving the growth of the gastrointestinal drugs market . For instance, in February 2020, Takeda Pharmaceutical Company Limited acquired PvP Biologics, Inc. This acquisition added investigational medicine TAK-062 (Kuma062) in the company's GI portfolio, which would be used for the treatment of uncontrolled celiac disease. The company is planning to submit data from the Phase 1 study for presentation at an upcoming medical congress. Globally, many people are living with celiac disease, and they manage their symptoms by following a gluten-free diet. There is still no treatment for people who experience severe symptoms. With this acquisition, the company is expecting to bring new therapies in the area of celiac disease management.

Drug Class-Based Insights

Based on drug class, the gastrointestinal drugs market is segmented into acid neutralizers, antidiarrheal and laxatives, anti-inflammatory drugs, antiemetic and antinauseants, biologics, and others. In 2019, the acid neutralizers segment accounted for the highest share of the market . Growth of this segment is attributed to increasing incidence of GERD and rising patient pool across the globe. However, the biologics segment is likely to register highest CAGR in the global gastrointestinal drugs market during the forecast period.

Route of Administration-Based Insights

In terms of route of administration, the gastrointestinal drugs market is segmented into oral and parenteral. The oral segment held the largest share of the market in 2019, whereas the same segment is expected to register the highest CAGR of 5.2% in the market during the forecast period.

Application-Based Insights

Based on application, the gastrointestinal drugs market is categorized into inflammatory ulcerative colitis, Crohn's disease, irritable bowel syndrome, gastroenteritis, celiac disease, and others. The inflammatory ulcerative colitis segment held the largest share of the market in 2019, whereas the irritable bowel syndrome segment is estimated to register the highest CAGR of 5.8% during the forecast period.

Distribution Channel-Based Insights

In terms of distribution channel, the gastrointestinal drugs market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment held the largest share of the market in 2019, and same segment is projected to register the highest CAGR of 5.4% in the market during the forecast period.

National Health Interview Survey, Guts Charity organization, National Center for Biotechnology Information, ClinicalTrials.gov., European Federation of Crohn's & Ulcerative Colitis Associations, Centers for Disease Control and Prevention, International Foundation for Gastrointestinal Disorders, Crohn’s & Colitis Foundation of America, American College of Gastroenterology, American Academy of Family Physicians, National Institutes of Health, Celiac Disease Foundation, International Trade Administration, InterAmerican Heart Foundation (FIC), Colombian Association of Integral Medicine Companies (ACEMI), are some of the major primary and secondary sources referred to whilepreparing this report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the gastrointestinal drugs market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global gastrointestinal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Gastrointestinal Drugs Market - By Drug Class
1.3.2 Gastrointestinal Drugs Market - By Route of Administration
1.3.3 Gastrointestinal Drugs Market - By Application
1.3.4 Gastrointestinal Drugs Market - By Distribution Channel
1.3.5 Global Gastrointestinal Drugs Market - By Geography
2. Gastrointestinal Drugs Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Gastrointestinal Drugs- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions
5. Gastrointestinal Drugs Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rise in Prevalence of Gastrointestinal (GI) Diseases
5.1.2 Increase in Development of Biologics
5.2 Market Restraints
5.2.1 Low Awareness Associated with Gastrointestinal Disorders in Low-Income Economies
5.3 Market Opportunities
5.3.1 Increasing Investment in Research Activities and Growing Pipeline of GI Candidates
5.4 Future Trends
5.4.1 Emergence of Biosimilars
5.5 Impact Analysis
6. Gastrointestinal Drugs Market - Global Analysis
6.1 Global Gastrointestinal Drugs Marker Revenue Forecast And Analysis
6.2 Global Gastrointestinal Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Gastrointestinal Drugs Market Analysis - By Drug Class
7.1 Overview
7.2 Gastrointestinal Drugs Market Revenue Share, by Drug Class (2019 and 2027)
7.3 Acid Neutralizers
7.3.1 Overview
7.3.2 Acid Neutralizers: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Antidiarrheal and Laxatives
7.4.1 Overview
7.4.2 Antidiarrheal and Laxatives: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Anti-Inflammatory Drugs
7.5.1 Overview
7.5.2 Anti-Inflammatory Drugs: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Antiemetic and Antinauseants
7.6.1 Overview
7.6.2 Antiemetic and Antinauseants: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Biologics
7.7.1 Overview
7.7.2 Biologics: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
8. Gastrointestinal Drugs Market Analysis - By Route of Administration
8.1 Overview
8.2 Gastrointestinal Drugs Market Share, by Route of Administration, 2019 and 2027
8.3 Oral
8.3.1 Overview
8.3.2 Oral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Parenteral
8.4.1 Overview
8.4.2 Parenteral: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9. Gastrointestinal Drugs Market Analysis - By Application
9.1 Overview
9.2 Gastrointestinal Drugs Market Revenue Share, by Application (2019 and 2027)
9.3 Inflammatory Ulcerative Colitis
9.3.1 Overview
9.3.2 Inflammatory Ulcerative Colitis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Crohn's Disease
9.4.1 Overview
9.4.2 Crohn's Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Irritable Bowel Syndrome
9.5.1 Overview
9.5.2 Irritable Bowel Syndrome: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Gastroenteritis
9.6.1 Overview
9.6.2 Gastroenteritis: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Celiac Disease
9.7.1 Overview
9.7.2 Celiac Disease: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10. Gastrointestinal Drugs Market Analysis - By Distribution Channel
10.1 Overview
10.2 Gastrointestinal Drugs Market Share, by Distribution Channel, 2019 and 2027
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.2 Hospital Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Pharmacies
10.4.1 Overview
10.4.2 Retail Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Online Pharmacies
10.5.1 Overview
10.5.2 Online Pharmacies: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
11. Gastrointestinal Drugs Market Analysis And Forecast To 2027 - Geographical Analysis
11.1 North America: Gastrointestinal Drugs Market
11.1.1 Overview
11.1.2 North America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.4 North America: Gastrointestinal Drugs Market, by Route of Administration, 2018-2027 (USD Million)
11.1.5 North America: Gastrointestinal Drugs Market, by Application, 2018-2027 (USD Million)
11.1.6 North America: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.7 North America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.1.8 US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.8.3 US: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.8.4 US: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.8.5 US: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.9 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.9.3 Canada: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.9.4 Canada: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.9.5 Canada: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.1.10 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.1.10.3 Mexico: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.1.10.4 Mexico: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.1.10.5 Mexico: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2 Europe: Gastrointestinal Drugs Market
11.2.1 Overview
11.2.2 Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.4 Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.5 Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.6 Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.7 Europe: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
11.2.8 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.8.3 Germany: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.8.4 Germany: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.8.5 Germany: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.9 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.9.3 UK: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.9.4 UK: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.9.5 UK: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.10 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.10.3 France: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.10.4 France: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.10.5 France: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.11 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.11.3 Spain: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.11.4 Spain: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.11.5 Spain: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.12 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.12.3 Italy: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.12.4 Italy: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.12.5 Italy: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.2.13 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.13.1 Rest of Europe: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.2.13.2 Rest of Europe: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.2.13.3 Rest of Europe: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.2.13.4 Rest of Europe: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.2.13.5 Rest of Europe: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3 Asia Pacific: Gastrointestinal Drugs Market
11.3.1 Overview
11.3.2 Asia Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.4 Asia Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.5 Asia Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.6 Asia Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.7 Asia Pacific: Gastrointestinal Drugs Market, by Country, 2018 & 2027 (%)
11.3.8 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.8.3 China: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.8.4 China: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.8.5 China: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.9 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.9.3 Japan: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.9.4 Japan: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.9.5 Japan: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.10 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.10.3 India: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.10.4 India: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.10.5 India: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.11 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.11.3 South Korea: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.11.4 South Korea: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.11.5 South Korea: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.12 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.12.3 Australia: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.12.4 Australia: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.12.5 Australia: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.3.13 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.13.1 Rest of Asia-Pacific: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.3.13.2 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Drug Class, 2018-2027 (USD Million)
11.3.13.3 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Route of Administration 2018-2027 (USD Million)
11.3.13.4 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Application 2018-2027 (USD Million)
11.3.13.5 Rest of Asia-Pacific: Gastrointestinal Drugs Market, by Distribution Channel, 2018-2027 (USD Million)
11.4 Middle East & Africa: Gastrointestinal Drugs Market
11.4.1 Overview
11.4.2 Middle East & Africa: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (US$ Million)
11.4.2.1 Middle East & Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.4.2.2 Middle East & Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.4.2.3 Middle East & Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.2.4 Middle East & Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.4.3.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.1.1 Saudi Arabia: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.2 Saudi Arabia Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.4.3.3 Saudi Arabia Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.4.3.4 Saudi Arabia Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.3.5 Saudi Arabia Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.4.3.6 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.6.1 UAE: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.4.3.7 UAE Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.4.3.8 UAE Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.4.3.9 UAE Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.3.10 UAE Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.5 South Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
11.5.1 South Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)
11.5.1.1 South Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.5.1.2 South Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.5.1.3 South Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.5.1.4 South Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.6 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts to 2025 (US$ Mn)
11.6.1 Rest of Middle East and Africa Gastrointestinal Drugs Market Revenue and Forecasts To 2027 (US$ Mn)
11.6.1.1 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.6.1.2 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.6.1.3 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.6.1.4 Rest of Middle East and Africa Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7 South and Central America: Gastrointestinal Drugs Market
11.7.1 Overview
11.7.2 South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.3 South and Central America: Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
11.7.4 South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.5 South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.6 South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7.7 South and Central America: Gastrointestinal Drugs Market, by Country, 2019 & 2027 (%)
11.7.8 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.8.1 Brazil: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.8.2 Brazil: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.7.8.3 Brazil: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.8.4 Brazil: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.8.5 Brazil: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7.9 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.9.1 Argentina: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.9.2 Argentina: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.7.9.3 Argentina: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.9.4 Argentina: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.9.5 Argentina: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.7.10 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.10.1 Rest of South and Central America: Gastrointestinal Drugs Market - Revenue and Forecast to 2027 (USD Million)
11.7.10.2 Rest of South and Central America: Gastrointestinal Drugs Market, by Therapeutic - Revenue and Forecast to 2027 (USD Million)
11.7.10.3 Rest of South and Central America: Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.7.10.4 Rest of South and Central America: Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.7.10.5 Rest of South and Central America: Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
12. Impact of COVID-19 Pandemic on Global Gastrointestinal Drugs Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
13. Gastrointestinal Drugs Market-Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 Sanofi
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 GlaxoSmithKline plc.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson and Johnson Services, Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bausch Health
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 AstraZeneca
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Takeda Pharmaceutical Company Limited
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AbbVie Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Bayer AG
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Celltrion Healthcare Co.,Ltd.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 LEXICON PHARMACEUTICALS, INC
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 Glossary of Terms
LIST OF TABLES
Table 1. North America Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Gastrointestinal Drugs Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. US Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 6. US Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. US Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 8. US Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Gastrointestinal Drugs Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. UK Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 26. UK Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 27. UK Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 28. UK Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. France Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 30. France Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 31. France Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 32. France Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 41. Rest of Europe Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 42. Rest of Europe Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 45. Asia Pacific Gastrointestinal Drugs Market, by Drug Class- Revenue and Forecast to 2027 (USD Million)
Table 46. Asia Pacific Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 47. Asia Pacific Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 48. Asia Pacific Gastrointestinal Drugs Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 49. China Gastrointestinal Drugs Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
Table 50. China Gastrointestinal Drugs Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 51. China Gastrointestinal Drugs Market, by Application- Revenue and Forecast to 2027 (USD Million)
Table 52. China Gastrointestinal D

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook